ProCE Banner Activity

Updates in High-Risk HR+ and/or gBRCAm+ Early-Stage Breast Cancer

Slideset Download
Downloadable slides on individualizing perioperative treatment for patients with high-risk HR-positive and/or germline BRCA–mutated early-stage breast cancer.

Released: June 03, 2022

Expiration: June 02, 2023

Share

Faculty

Jennifer K. Litton

Jennifer K. Litton, MD

Associate Professor of Medicine
Department of Breast Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Lilly

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Jennifer K. Litton, MD

Associate Professor of Medicine
Department of Breast Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas